Stereotactic body radiation therapy plus adoptive vNKT cell therapy for pancreatic cancer: protocol of a phase II trial

Authors

Institutions

Publication Details

Journal
Immunotherapy
Published
2025-07-16
DOI
https://doi.org/10.1080/1750743x.2025.2533112
Citations
2
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
2.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stereotactic body radiation therapy plus adoptive vNKT cell therapy for pancreatic cancer: protocol of a phase II trial

Lingong Jiang, Sheng Xia, Xiaolan Yin, Minghui Zhang et al.
2 citations
Immunotherapy
CAR-T cell therapy research
2.09
article

Stereotactic body radiation therapy plus adoptive vNKT cell therapy for pancreatic cancer: protocol of a phase II trial

Lingong Jiang, Sheng Xia, Xiaolan Yin, Minghui Zhang, Wenyu Liu, Yangsen Cao, Huojun Zhang, Zhenhong Guo, Xiaofei Zhu, Chunshan Yu
article en
2 citations

Abstract

No abstract available for this paper.
ImmunotherapyVol. 17(10)
Jiangsu University (CN), Second Military Medical University (CN), Changhai Hospital (CN), Rongsheng Petrochemical (China) (CN), People's Liberation Army 411 Hospital (CN), Tsinghua University (CN)
National Natural Science Foundation of China, Changhai Hospital of Shanghai
Good health and well-being
Openalex Percentile: Top 11%
CAR-T cell therapy research
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Stereotactic body radiation therapy plus adoptive vNKT cell therapy for pancreatic cancer: protocol of a phase II trial — Lingong Jiang, Sheng Xia, et al. · Immunotherapy (2025) | TGRS Research Map | TGRS